Literature DB >> 15542682

Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.

John G Julias1, Mary Jane McWilliams, Stefan G Sarafianos, W Gregory Alvord, Eddy Arnold, Stephen H Hughes.   

Abstract

The RNase H cleavages that generate and remove the polypurine tract (PPT) primer during retroviral reverse transcription must be specific in order to create a linear viral DNA that is suitable for integration. Lentiviruses contain a highly conserved sequence consisting of six guanine residues at the 3' end of the PPT (hereafter referred to as the G tract). We introduced mutations into the G tract of a human immunodeficiency virus type 1-based vector and determined the effects on the virus titer and RNase H cleavage specificity. Most mutations in the G tract had little or no effect on the virus titer. Mutations at the second and fifth positions of the G tract increased the proportion of two-long-terminal-repeat (2-LTR) circle junctions with one or two nucleotide insertions. The second and fifth positions of the G tract make specific contacts with amino acids in the RNase H domain that are important for RNase H cleavage specificity. These complementary data define protein-nucleic acid interactions that help control the specificity of RNase H cleavage. When the G-tract mutants were analyzed in a viral background that was deficient in integrase, in most cases the proportion of consensus 2-LTR circle junctions increased. However, in the case of a mutant with Ts at the second and fifth positions of the G tract, the proportion of 2-LTR circle junctions containing the one-nucleotide insertion increased, suggesting that linear viral DNAs containing an extra base are substrates for integration. This result is consistent with the idea that the 3' end-processing reactions of retroviral integrases may help to generate defined ends from a heterogenous population of linear viral DNAs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542682      PMCID: PMC524982          DOI: 10.1128/JVI.78.23.13315-13324.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; Edward Arnold; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H.

Authors:  A J Rattray; J J Champoux
Journal:  J Mol Biol       Date:  1989-08-05       Impact factor: 5.469

5.  Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity.

Authors:  Jason W Rausch; Daniela Lener; Jennifer T Miller; John G Julias; Stephen H Hughes; Stuart F J Le Grice
Journal:  Biochemistry       Date:  2002-04-16       Impact factor: 3.162

6.  Pre-existing distortions in nucleic acid structure aid polypurine tract selection by HIV-1 reverse transcriptase.

Authors:  Mamuka Kvaratskhelia; Scott R Budihas; Stuart F J Le Grice
Journal:  J Biol Chem       Date:  2002-03-01       Impact factor: 5.157

7.  Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA.

Authors:  F D Bushman; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  An unusual sugar conformation in the structure of an RNA/DNA decamer of the polypurine tract may affect recognition by RNase H.

Authors:  Mary L Kopka; Laurence Lavelle; Gye Won Han; Ho-Leung Ng; Richard E Dickerson
Journal:  J Mol Biol       Date:  2003-12-05       Impact factor: 5.469

10.  Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.

Authors:  James S Buckman; William J Bosche; Robert J Gorelick
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  20 in total

1.  Integration of rous sarcoma virus DNA: a CA dinucleotide is not required for integration of the U3 end of viral DNA.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

Review 2.  Recent findings on the mechanisms involved in tenofovir resistance.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Antivir Chem Chemother       Date:  2014-12-16

3.  Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by rous sarcoma virus RNase H but do cause aberrant integrations in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; Stephen H Hughes
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Alternate polypurine tracts affect rous sarcoma virus integration in vivo.

Authors:  Jangsuk Oh; Kevin W Chang; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Alternate polypurine tracts (PPTs) affect the rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction.

Authors:  Kevin W Chang; John G Julias; W Gregory Alvord; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate.

Authors:  Jangsuk Oh; Kevin W Chang; Rafal Wierzchoslawski; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

Review 9.  Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

Authors:  James J Champoux; Sharon J Schultz
Journal:  FEBS J       Date:  2009-02-18       Impact factor: 5.542

Review 10.  RNase H activity: structure, specificity, and function in reverse transcription.

Authors:  Sharon J Schultz; James J Champoux
Journal:  Virus Res       Date:  2008-02-07       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.